Mass Oral Azithromycin for Childhood Mortality: Timing of Death After Distribution in the MORDOR Trial.
Porco, Travis C; Hart, John
; Arzika, Ahmed M; Weaver, Jerusha; Kalua, Khumbo; Mrango, Zakayo; Cotter, Sun Y; Stoller, Nicole E; O'Brien, Kieran S; Fry, Dionna M; +7 more...Vanderschelden, Benjamin; Oldenburg, Catherine E; West, Sheila K; Bailey, Robin L
; Keenan, Jeremy D; Lietman, Thomas M; and Macrolides Oraux pour Réduire les Décès avec un Oeil sur la Rési
(2019)
Mass Oral Azithromycin for Childhood Mortality: Timing of Death After Distribution in the MORDOR Trial.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 68 (12).
pp. 2114-2116.
ISSN 1058-4838
DOI: 10.1093/cid/ciy973
In a large community-randomized trial, biannual azithromycin distributions significantly reduced postneonatal childhood mortality in sub-Saharan African sites. Here, we present a prespecified secondary analysis showing that much of the protective effect was in the first 3 months postdistribution. Distributing more frequently than biannually could be considered if logistically feasible. Clinical Trials Registration. NCT02047981.
Item Type | Article |
---|---|
Elements ID | 133849 |
Date Deposited | 08 Jul 2019 13:32 |
ORCID: https://orcid.org/0000-0002-9637-7974
ORCID: https://orcid.org/0000-0002-8770-1680